oral glp-1 agonist Danuglipron: An GLP-1R Competing with Peptide Injectables for Diabetes and Obesity Frontiers | Glucagon-like peptide-1 receptor
Description
Diabetes Obes Metab (2016) 18:4919
Semaglutide first gained US regulatory approval under the brand name Ozempic as a treatment for type 2 diabetes in December 2017
Comparison of Single and Combined Treatment With Exenatide and Metformin on Menstrual Cyclicity in Overweight Women With Polycystic Ovary Syndrome
GLP-1 Receptor Agonist Promotes Brown Remodelling in Mouse White Adipose Tissue Through SIRT1
